Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PPD Appoints EVP, CFO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

PPD Appoints EVP, CFO

Hureau brings 25 years of financial experience

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Robert Hureau has been appointed executive vice president and chief financial officer at PPD. Mr. Hureau has 25 years of experience and financial expertise in the medical technology/life sciences, manufacturing and consumer sectors. He will be based in PPD’s headquarters in Wilmington.
 
Mr. Hureau joined the company from Centaur Guernsey L.P. Inc., a global medical technology company, where he served as executive vice president and chief financial officer. Previously, he held a series of senior leadership positions, including senior vice president and chief financial officer at Sensata Technologies N.V., and vice president of finance with The Jean Coutu Group (PJC) U.S.A., Inc.
 
“Bob is an accomplished chief financial officer who will uphold PPD’s long-standing reputation as a company committed to integrity, financial discipline and sustainable growth,” said David Simmons, PPD’s chairman and chief executive officer. “We are confident Bob’s experience, strong business mind and financial acumen will complement and aid PPD’s focus on delivering value for our biopharmaceutical clients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters